The National Institutes of Health has awarded US$11 million to the University of Kentucky (UK) to establish a new diabetes-prevention research centre, the UK Diabetes Prevention COBRE (UK-DPC).

The grant, spanning five years, marks a major boost to efforts to tackle the rising burden of diabetes in Kentucky.

:contentReference[oaicite:2]{index=2}

Under the award, UK will expand research infrastructure, support translational programmes, and build a network aimed at preventing type-2 diabetes across the Commonwealth.

The programme will be co-led by Simon Fisher, director of the Barnstable Brown Diabetes Center and head of the Division of Endocrinology, Diabetes and Metabolism, and Barbara Nikolajczyk, associate director for translational research.

:contentReference[oaicite:5]{index=5}

Kentucky faces a particularly acute challenge: recent estimates suggest as many as 38 percent of adults in the state have pre-diabetes, placing a large portion of the population at risk of developing full-blown type-2 diabetes.

:contentReference[oaicite:6]{index=6} Amid that backdrop, university leaders described the new funding as “transformative,” not only for research but also for public-health outreach and long-term prevention strategies.

:contentReference[oaicite:7]{index=7}

The UK-DPC will integrate existing clinical programmes, epidemiological studies, and community outreach to address diabetes risk factors statewide.

It will also support the training and mentoring of early-career investigators, helping build a sustainable research workforce focused on metabolic health and preventive medicine.

:contentReference[oaicite:8]{index=8}

University officials emphasised that the COBRE grant complements existing research investments, including support from private philanthropy and other funding sources — and will help the institution expand its role as a national leader in diabetes prevention and metabolic disease research.

:contentReference[oaicite:9]{index=9}

With diabetes and pre-diabetes rates among the highest in the United States, the new UK-DPC represents a strategic effort to translate research into actionable prevention, improve health outcomes, and alleviate the long-term burden of chronic disease across Kentucky communities.

As the centre ramps up, attention will focus on its ability to deliver meaningful public-health impacts, promote equitable access to preventive care, and serve as a model for other regions facing similar diabetes epidemics.